Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Resmed Inc (RMD)

Resmed Inc (RMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 41,406,908
  • Shares Outstanding, K 145,681
  • Annual Sales, $ 3,197 M
  • Annual Income, $ 474,510 K
  • 60-Month Beta 0.30
  • Price/Sales 13.03
  • Price/Cash Flow 44.28
  • Price/Book 14.92
Trade RMD with:

Options Overview

Details
  • Implied Volatility 30.69%
  • Historical Volatility 15.88%
  • IV Percentile 58%
  • IV Rank 35.19%
  • IV High 48.80% on 10/29/20
  • IV Low 20.86% on 06/11/21
  • Put/Call Vol Ratio 1.19
  • Today's Volume 219
  • Volume Avg (30-Day) 196
  • Put/Call OI Ratio 0.84
  • Today's Open Interest 2,222
  • Open Int (30-Day) 3,425

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate 1.35
  • Number of Estimates 3
  • High Estimate 1.47
  • Low Estimate 1.26
  • Prior Year 1.27
  • Growth Rate Est. (year over year) +6.30%

Price Performance

See More
Period Period Low Period High Performance
1-Month
280.87 +1.20%
on 09/20/21
301.34 -5.68%
on 09/09/21
-1.46 (-0.51%)
since 08/20/21
3-Month
235.90 +20.49%
on 06/21/21
301.34 -5.68%
on 09/09/21
+46.79 (+19.71%)
since 06/18/21
52-Week
165.72 +71.51%
on 09/21/20
301.34 -5.68%
on 09/09/21
+114.22 (+67.18%)
since 09/18/20

Most Recent Stories

More News
4 Soaring Medical Device Stocks to Buy Now

The medical devices industry has been performing remarkably well over the past year. And we think this trend will likely continue, driven by rising demand for non-emergency medical procedures and tech...

RMD : 284.23 (-0.60%)
ALC : 84.21 (-0.15%)
TRUMY : 48.6750 (-1.66%)
WST : 444.65 (-0.88%)
ResMed (RMD)-Backed Landmark ALASKA Study Favors PAP Therapy

A late-breaking abstract from ResMed (RMD) supported landmark ALASKA study reported that treatment with PAP therapy improves the likelihood of longevity in sleep apnea patients

RMD : 284.23 (-0.60%)
VREX : 28.23 (-2.39%)
NVST : 41.58 (-2.23%)
BRBR : 31.22 (-1.98%)
ResMed Announces Participation in the Bank of America Global Healthcare Conference

ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will participate in a virtual fireside chat at the Bank of America Global Healthcare Conference on Wednesday,...

RMD : 284.23 (-0.60%)
People with Sleep Apnea Live Longer on CPAP in Large, Late-Breaking ResMed-Supported ALASKA Study Presented at ERS

Using PAP (positive airway pressure) therapy as directed can significantly increase sleep apnea patients' chances of living longer, according to a late-breaking abstract presented today at the virtual...

RMD : 284.23 (-0.60%)
ResMed Announces SaaS Leadership Change

Change intended to drive rapid digital transformation, leverage full scale of cloud-connected technology platforms, and accelerate growth of ResMed's SaaS business

RMD : 284.23 (-0.60%)
Supermoon Capital Launches with World's First Fund Focused on Sleep

/PRNewswire/ -- Supermoon Capital (), formerly SleepScore Ventures, launched today with its first venture fund of to invest in early-stage startups across all geographies working on science-backed innovations...

NVRO : 124.20 (-1.92%)
RMD : 284.23 (-0.60%)
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

RMD : 284.23 (-0.60%)
ResMed's (RMD) AirSense 11 to Boost Sleep Apnea Digitalization

ResMed's (RMD) new launch will make therapy setup easier for patients and help clinicians offer care more efficiently.

RMD : 284.23 (-0.60%)
HSIC : 75.97 (-1.94%)
NVST : 41.58 (-2.23%)
BRBR : 31.22 (-1.98%)
ResMed (RMD) Hits New 52-Week High: What's Behind the Rally?

Investors are optimistic about ResMed's (RMD) potential in digital health and its strong emphasis on product development.

ISRG : 1,013.99 (-2.24%)
RMD : 284.23 (-0.60%)
HSIC : 75.97 (-1.94%)
IDXX : 659.78 (-0.29%)
Here's Why You Should Add Henry Schein (HSIC) to Your Portfolio

Strong performance by the Dental, Medical & Technology and Value-Added Services segments is driving Henry Schein's (HSIC) top line.

RMD : 284.23 (-0.60%)
HSIC : 75.97 (-1.94%)
IDXX : 659.78 (-0.29%)
WST : 444.65 (-0.88%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

ResMed Inc. is a world-leading connected health company with cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions....

See More

Key Turning Points

3rd Resistance Point 292.98
2nd Resistance Point 289.88
1st Resistance Point 287.06
Last Price 284.23
1st Support Level 281.14
2nd Support Level 278.04
3rd Support Level 275.22

See More

52-Week High 301.34
Last Price 284.23
Fibonacci 61.8% 249.53
Fibonacci 50% 233.53
Fibonacci 38.2% 217.53
52-Week Low 165.72

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar